"Performance" VENUS MEDTECH's annual loss narrowed to 408 million RMB, no dividend declared
VENUS MEDTECH (02500.HK) announced its full-year results for the year ending last December, with revenue of RMB 307 million, a year-on-year decrease of 34.8%. Losses narrowed to RMB 408 million, compared to a loss of RMB 714 million in the same period last year; loss per share was RMB 0.93. No dividend was declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments